Methods
thyroid swelling
THYROTOXICOSIS, BLEEDING DIATHESIS
A prospective, randomized study was carried out on 54 patients for 18 months from March 2021 to July 2022. We included patients of both genders of all age groups in a euthyroid state with clinically proven and cytologically diagnosed thyroid swelling requiring surgical removal. The exclusion criteria were patients with thyrotoxicosis, on anticoagulants, bleeding diathesis, with huge thyroids more than 6 cm and patients for whom lateral neck dissection was required. They were evaluated using ultrasound neck, thyroid hormone profile (FT3, FT4, TSH), fine needle aspiration cytology (FNAC), Indirect Laryngoscopy and routine pre-operative blood investigations, which included a complete hemogram with coagulation profile, renal and liver function tests, serum electrolytes, serology, urine routine, chest x-ray, neck x-rays, and electrocardiogram (ECG). In addition, the pre-operative evaluation also included 2D echo and pulmonary function tests (PFTs) in applicable patients. Informed consent for surgery and participation in the study was obtained from the patient. A senior surgeon operated on all the patients with strict adherence to intraoperative surgical protocols. Thorough hemostasis and meticulous closure was followed to identify and preserve recurrent laryngeal nerves. Intraoperatively, the patients were allocated using the block randomization method into the drain group (Group A, - Post operative image of patient in the drain group.- Post operative image of patient in the no drain group.The study was carried out in accordance with the 1964 Declaration of Helsinki and its subsequent amendments or comparable ethical standards. The protocol of the study was approved by the Institutional Review Board and the Ethics Committee of our hospital.